Netherlands Cardiac Surgery Instruments Market Report 2022 to 2030

Netherlands Cardiac Surgery Instruments Market Analysis

$ 3999

The Netherlands Cardiac Surgery Instruments Market is expected to witness growth from $5 Mn in 2022 to $9 Mn in 2030 with a CAGR of 7.10% for the forecasted year 2022-2030. The demand for cardiac surgery instruments is anticipated to rise in the Netherlands as a result of a growing elderly population and the rising incidence of cardiovascular illnesses. The market is segmented by type, application and by end user. Some key players in this market include Hy2Care B.V, InnoSer, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.

ID: IN10NLMD004 CATEGORY: Medical Devices GEOGRAPHY: Netherlands AUTHOR: Jigyasu Bhandari

Buy Now

Netherlands Cardiac Surgery Instruments Healthcare Market Executive Analysis

The Netherlands Cardiac Surgery Instruments Market size is at around $5 Mn in 2022 and is projected to reach $9 Mn in 2030, exhibiting a CAGR of 7.10% during the forecast period. In the Netherlands, healthcare costs represented 10.5% of GDP, and together co-payments (11%), general taxation (22%), employer-paid salary taxes (46%), and general taxation (22%) covered 81% of that expenditure. The Netherlands spent $5.33 million on each individual's healthcare in 2019. A cumulative annual growth rate of 5.64% was used to calculate the rise in health spending in the Netherlands from $3.03 million in 2015 to $6 million in 2022.

In the Netherlands, cardiovascular disease is the main cause of death and disability; there are about 1.4 million people in the country who have the condition. Around 28% of all deaths in the Netherlands are caused by heart illness, making it the country's highest mortality. In the Netherlands, there will be about 19,000 mortalities from heart disease in 2022. In the Netherlands, atrial fibrillation (an irregular pulse) affects 1.4% of people and becomes more common as people get elder. In the Netherlands, approximately 30% of people have high blood pressure, which is a significant risk factor for cardiovascular disease.

In the Netherlands, using cardiac surgery instruments improves surgical accuracy, lowers the chance of complications, and improves patient outcomes. Minimally invasive procedures, which have fewer incisions, less discomfort, less scarring, and quicker recovery times, also use cardiac surgery tools. Pacemakers, which are tiny devices placed beneath the skin of the chest to control the heart's rhythm, are also implanted using cardiac surgery tools. In order to manage arrhythmias or irregular heartbeats, pacemakers are used. Atrial fibrillation, an irregular pulse, is treated surgically using cardiac surgery tools. In order to lower the risk of stroke and return the heart rhythm to normal, surgery is done. Coronary Artery Bypass Grafting (CABG) is a surgical technique that employs tools from cardiac surgery to bypass coronary arteries that are blocked or constrained. The treatment is used to increase the heart's blood flow and lower the risk of a heart attack.

Netherlands Cardiac Surgery Instruments Market Analysis

Market Dynamics

Market Growth Drivers

Heart disease is still the main cause of morbidity and mortality in the Netherlands. Due to the rising occurrence of cardiovascular illnesses, it is predicted that there will be a constant demand for cardiac surgery instruments. Rapid technological progress is converting the instruments used in cardiac surgery, enabling new chances for manufacturers to develop cutting-edge products that improve surgical precision and patient outcomes. As an illustration, the advent of robotic-assisted surgery systems has made it possible to conduct minimally invasive cardiac surgery, which reduces recovery time and improves patient fulfilment. As the elderly population in the Netherlands grows and cardiovascular diseases become more common, it is expected that demand for cardiac surgery tools will increase.

Market Restraints

In the Netherlands, the use of medication treatment, catheter-based procedures, and other minimally invasive or non-invasive cardiac interventions that don't involve surgery is becoming more popular. Because of this, there might be less desire for cardiac surgery equipment in the Netherlands. Due to their expensive price in the Netherlands, some healthcare professionals and patients may not be able to afford cardiac surgery equipment. This might reduce consumer desire in the Dutch market for cardiac surgery equipment for these instruments.

Competitive Landscape

Key Players

Hy2Care B.V (NL)
InnoSer (NL)
LivaNova
B. Braun
KLS Martin
Medline Industries
STILLE

Healthcare Policies and Regulatory Landscape

In the Netherlands, a few of the agencies that monitor the legal framework and professional standards in the market for cardiac surgery instruments are the Dutch Healthcare Authority (NZa), the Ministry of Health, Welfare and Sport (VWS), and the Healthcare Inspectorate (IGJ). Medical device laws like the Medical Devices Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR), which seek to ensure the safety and efficacy of medical devices marketed in the EU, apply to all medical devices, including those used in cardiac surgery. The expense and insurance reimbursement of medical devices, including those used in cardiac surgery, are governed by the Dutch Healthcare Authority (NZa). The NZ launches maximum rates for medical devices, which serve as the foundation for insurers' reimbursement policies. In addition, the Dutch Healthcare Authority (NZa) is in charge of regulating the costs and insurance coverage of medical equipment, including those used in cardiac surgery. The NZa establishes maximum rates for medical equipment, which serve as the foundation for insurers' reimbursement policies. Instruments used in cardiac surgery are subject to laws pertaining to the safety and quality of medical devices, which are monitored and enforced by the Healthcare Inspectorate (IGJ). To make sure that laws are being followed, the IGJ inspects companies that make medical devices, and it has the authority to initiate enforcement actions against those businesses.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cardiac Surgery Instruments Market Segmentation

By Type (Revenue, USD Billion):

The market is divided into segments in this study based on the goods, applications, end users, and geographical areas. The market is divided into forceps, scissors, needle holders, clamps, and other cardiac surgery instruments based on the product. In 2017 the forceps category led the market, and it is anticipated that it will increase at the fastest rate going forward. The rise in heart surgeries and the frequent usage of forceps in most cardiac procedures are credited with the segment's strong growth.

Forceps
Vascular Forceps
Grasping Forceps
Other Forceps
Needle Holders
Scissors
Clamps
Other Cardiac Surgical Instruments

By Application (Revenue, USD Billion):

The market is further segmented by application into paediatric cardiac surgery, heart valve surgery, coronary artery bypass graft (CABG), and other applications. The Netherlands market's largest and fastest-growing application segment is CABG. This is mostly explained by the increased prevalence of heart illnesses and the consequent rise in surgical treatments. The second-largest category is heart valve surgery.

Coronary Artery Bypass Graft (CABG)
Heart Valve Surgery
Pediatric Cardiac Surgery
Other Applications

By End User (Revenue, USD Billion):

Based on the end user, the market is segmented into hospitals and cardiac centers, and ambulatory surgery centers. The hospitals and cardiac centers segment is expected to dominate the market for cardiac surgery instruments. Growth in this end-user segment can be attributed to the increasing incidence of cardiac and heart valve diseases and the subsequent increase in the number of cardiac surgery procedures.

Hospitals and Cardiac Centers
Ambulatory Surgery Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.